Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset

Collongues, N.; Marignier, R.; Jacob, A.; Leite, M.; Sivas, A.; Paul, F.; Zephir, H.; Akman-Demirs, G.; Elsone, L.; Jarius, S.; Papeix, C.; Mutch, K.; Saips, S.; Wildemann, B.; Kitley, J.; Karabudak, R.; Aktas, O.; Kuscu, D.; Altintas, A.; Palace, J.; Confavreux, C.; De Seze, J.

doi:10.1177/1352458513515085

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset

Atıf İçin Kopyala

Collongues N., Marignier R., Jacob A., Leite M. I., Sivas A., Paul F., ...Daha Fazla

MULTIPLE SCLEROSIS JOURNAL, cilt.20, sa.8, ss.1086-1094, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20 Sayı: 8
Basım Tarihi: 2014
Doi Numarası: 10.1177/1352458513515085
Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1086-1094
Hacettepe Üniversitesi Adresli: Evet

Özet

Background: Few data are available for patients with a late onset (>= 50 years) of neuromyelitis optica (LONMO) or neuromyelitis optica spectrum disease (LONMOSD), defined by an optic neuritis/longitudinally extensive transverse myelitis with aquaporin-4 antibodies (AQP4-Ab).